articleTop 10% cited
Design, synthesis and biological evaluations of novel oxindoles as HIV-1 non-nucleoside reverse transcriptase inhibitors. Part I
Bioorganic & Medicinal Chemistry Letters · 2006 · Vol. 16(8) · pp. 2105–2108
Tao Jiang(Genomics Institute of the Novartis Research Foundation)Kelli Kuhen(Genomics Institute of the Novartis Research Foundation)Karen C. Wolff(Genomics Institute of the Novartis Research Foundation)Hong Yin(Genomics Institute of the Novartis Research Foundation)Kimberly Bieza(Genomics Institute of the Novartis Research Foundation)Jeremy S. Caldwell(Genomics Institute of the Novartis Research Foundation)Badry Bursulaya(Genomics Institute of the Novartis Research Foundation)Tom Yao‐Hsing Wu(Scripps Research Institute)Yun He✉(Genomics Institute of the Novartis Research Foundation)
HIV/AIDS drug development and treatmentHIV Research and TreatmentPneumocystis jirovecii pneumonia detection and treatmentReverse transcriptaseChemistryOxindoleNucleosideNucleoside Reverse Transcriptase InhibitorHuman immunodeficiency virus (HIV)NucleotidyltransferaseChemical synthesisReverse-transcriptase inhibitorNucleoside analogue
MeSH terms
IndolesStereoisomerismStructure-Activity RelationshipVirus ReplicationHIV-1Reverse Transcriptase InhibitorsAnti-HIV AgentsDrug Resistance, Viral
Citations
292
FWCI
3.46
field-weighted impact
References
18
Percentile
93%
vs. same field & year
Citations per year
Cited by
Transition‐Metal‐Mediated Routes to 3,3‐Disubstituted Oxindoles through Anilide Cyclisation
European Journal of Organic Chemistry · 2011 · 309 citations
References
Declining Morbidity and Mortality among Patients with Advanced Human Immunodeficiency Virus Infection
New England Journal of Medicine · 1998 · 9,489 citations
Citation Network
How this paper connects to the literature. Drag to explore, click any node to open that paper.